Clinical Trials Directory

Trials / Completed

CompletedNCT05581836

The Effect of Central Sensitization and Neuropathic Pain After Total Knee Arthroplasty

The Effect of Central Sensitization and Neuropathic Pain on Patients Reported Outcomes Following Total Knee Arthroplasty

Status
Completed
Phase
Study type
Observational
Enrollment
312 (actual)
Sponsor
The Catholic University of Korea · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers

Summary

It has been well known that central sensitization (CS) is a risk factor for inferior outcomes following total knee arthroplasty (TKA). However, there are still insufficient studies on the relationship between CS and neuropathic pain (NP), and the effects of CS and NP on the patient-reported outcome measures (PROMs) of patients who underwent TKA. The purpose of this study was to investigate the relationship between CS and NP and whether CS and NP were associated with PROM in patients undergoing TKA.

Detailed description

A total of 312 patients who underwent primary TKA for end stage knee OA were enrolled. CS was defined as a patient with a score of 40 or higher using central sensitization inventory (CSI). NP was defined as a patient with a score of 12 or more using pain detect questionnaire (PDQ). PROMs were also evaluated based on the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score preoperatively and at postoperative 1 year. The patients were divided into 4 groups, group 1 with CS and NP positive, group 2 with only CS positive, group 3 with only NP positive, and group 4 with CS and NP negative, and PROM was compared between the groups.

Conditions

Timeline

Start date
2019-01-01
Primary completion
2021-12-31
Completion
2021-12-31
First posted
2022-10-17
Last updated
2022-10-19

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT05581836. Inclusion in this directory is not an endorsement.